mTOR signaling in skeletal myogenesis
mTOR signaling in skeletal myogenesis
批准号:
7772278
负责人:
Jie Chen
金额:
$33.23万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-01 至 2014-02-28
关键词:
AddressAgeAgingAmino AcidsAnimal ModelBiochemicalBiologyBreedingCell LineDataDifferentiation and GrowthDiseaseEndocrineExerciseFollistatinGeneticGoalsGrantGrowthHypertrophyIn VitroInsulin-Like Growth Factor IIKnowledgeLaboratoriesMediatingMolecularMusMuscleMuscle CellsMuscle DevelopmentMuscle FibersMuscular AtrophyMuscular DystrophiesMyoblastsNatural regenerationNutrientPathway interactionsPhosphotransferasesPhysiologicalPositioning AttributeProcessProductionRNA InterferenceRegulationResistanceRoleSignal TransductionSignal Transduction PathwaySirolimusSkeletal MuscleStagingSystemTestingTransgenic MiceValidationWorkautocrinecell growthchemokinecytokinegenome-widein vivoinhibitor/antagonistmTOR proteinmuscle hypertrophymuscle regenerationmutantmyogenesisnovelparacrinepublic health relevancerepairedresponseskeletalskeletal muscle differentiationskeletal muscle growth
中文摘要
描述(由申请人提供):骨骼肌分化是一个精心策划的过程,由自分泌、旁分泌和内分泌因子通过信号转导途径的调节网络进行调节。近年来,哺乳动物雷帕霉素靶蛋白(mTOR)开始被认为是骨骼肌分化、生长和肥大的关键调节因子。我们实验室的工作促进了目前对mTOR调节成肌细胞分化的理解,并揭示了mTOR通过组装不同的途径调节肌发生的多个阶段,其中一些是意想不到的,尚未完全阐明。结合生物化学、分子、细胞和遗传学方法,并利用体外和体内系统,我们的目标是通过解决以下三个主要问题来填补目前对骨骼肌发生调控的分子途径的认识中的相当大的空白:(1)已知的生长调节mTOR通路的组分如何参与肌生成,什么是mTOR通路,调节成肌细胞分化的启动,以响应氨基酸的可用性信号?(2)什么是mTOR途径,专门调节第二阶段的肌细胞融合的关键肌管/肌纤维的生长和成熟,哪些分泌因子调节这一过程?(3)mTOR在肌肉再生中的作用是什么,机制是什么?我们在信号转导机制的生化表征方面的专业知识,我们强大的初步数据,以及我们创建的独特动物模型,使我们处于解决这些问题的理想位置。从这些研究中获得的知识将有助于从分子水平了解骨骼肌的发育、修复、再生和肥大。公共卫生相关性:骨骼肌分化是一个由自分泌、旁分泌和内分泌因子通过多种信号转导途径调控的协调过程。我们的研究旨在剖析骨骼肌分化和再生调控的分子机制,重点是雷帕霉素信号网络的哺乳动物靶点。在这些研究中获得的知识将有助于对骨骼肌生物学的分子理解,这可能对健康相关问题产生重大影响,例如肌营养不良、衰老或疾病引起的肌肉萎缩、肌肉再生和运动引起的肌肉肥大。
英文摘要
DESCRIPTION (provided by applicant): Skeletal muscle differentiation is a well-orchestrated process regulated by autocrine, paracrine, and endocrine factors via a regulatory network of signal transduction pathways. In recent years the mammalian target of rapamycin (mTOR) has begun to be recognized as a critical regulator of skeletal muscle differentiation, growth and hypertrophy. Work from our laboratory has contributed to the current understanding of mTOR regulation of myoblast differentiation, and has led to the revelation that mTOR regulates multiple stages of myogenesis by assembling distinct pathways, some of which unexpected and yet to be fully delineated. With a combination of biochemical, molecular, cellular and genetic approaches, and utilizing both in vitro and in vivo systems, we aim to fill a sizable gap in the current knowledge of molecular pathways underlying the regulation of skeletal myogenesis by addressing these three major questions: (1) How are the known components of growth-regulating mTOR pathway involved in myogenesis, and what is the mTOR pathway(s) that regulates the initiation of myoblast differentiation in response to amino acids availability signals? (2) What is the mTOR pathway that specifically regulates the second-stage myocyte fusion critical for myotube/myofiber growth and maturation, and which secreted factors regulate this process? (3) What is mTOR's role in muscle regeneration and what are the mechanisms? Our expertise in biochemical characterization of signal transduction mechanisms, our strong preliminary data, and the unique animal models we have created, put us in an ideal position to tackle those questions. Knowledge gained in these studies will contribute to the molecular understanding of skeletal muscle development, repair, regeneration and hypertrophy. PUBLIC HEALTH RELEVANCE: Skeletal muscle differentiation is a well-orchestrated process regulated by autocrine, paracrine, and endocrine factors via multiple signal transduction pathways. Our proposed studies aim to dissect the molecular mechanisms underlying the regulation of skeletal muscle differentiation and regeneration, with a focus on the mammalian target of rapamycin signaling network. Knowledge gained in these studies will contribute to the molecular understanding of skeletal muscle biology, which may have significant impact on health-related issues such as muscular dystrophy, aging or disease-induced muscle atrophy, muscle regeneration, and exercise- induced muscle hypertrophy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The impact of hospital-based health information technology on health care quality and equity among patients with ADRD
-
批准号:10729695
-
项目类别:
-
资助金额:$193.36万
-
财政年份:2023
-
负责人:Jie Chen
-
依托单位:
Effect of Hospital and Community Care Coordination on Health Care Quality and Equity among Individuals with Risk Factors or Diagnosis of ADRD
-
批准号:10589023
-
项目类别:
-
资助金额:$57.97万
-
财政年份:2021
-
负责人:Jie Chen
-
依托单位:
Effect of Hospital and Community Care Coordination on Health Care Quality and Equity among Individuals with Risk Factors or Diagnosis of ADRD
-
批准号:10353407
-
项目类别:
-
资助金额:$49.41万
-
财政年份:2021
-
负责人:Jie Chen
-
依托单位:
Effect of Hospital and Community Care Coordination on Health Care Access, Quality and Equity among Individuals with Risk Factors or Diagnosis of ADRD
-
批准号:9789164
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2018
-
负责人:Jie Chen
-
依托单位:
Effects of Hospital-Community-Public Health Integration on Racial and Ethnic Disparities in Mental Health
-
批准号:9924656
-
项目类别:
-
资助金额:$54.09万
-
财政年份:2017
-
负责人:Jie Chen
-
依托单位:
Effects of Hospital-Community-Public Health Integration on Racial and Ethnic Disparities in Mental Health
-
批准号:10021780
-
项目类别:
-
资助金额:$8.36万
-
财政年份:2017
-
负责人:Jie Chen
-
依托单位:
Effects of Hospital-Community-Public Health Integration on Racial and Ethnic Disparities in Mental Health
-
批准号:9329801
-
项目类别:
-
资助金额:$41.43万
-
财政年份:2017
-
负责人:Jie Chen
-
依托单位:
Effect of Local Health Departments on Health Care Disparities for Individuals with Mental Health Disorders
-
批准号:9199107
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2016
-
负责人:Jie Chen
-
依托单位:
Effect of Local Health Departments on Health Care Disparities for Individuals with Mental Health Disorders
-
批准号:9034884
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2016
-
负责人:Jie Chen
-
依托单位:
Single-Molecule Dissection of mTOR Complexes
-
批准号:8469719
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2013
-
负责人:Jie Chen
-
依托单位:
Single-Molecule Dissection of mTOR Complexes
-
批准号:8738558
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2013
-
负责人:Jie Chen
-
依托单位:
Phospholipase D signaling
-
批准号:8708111
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2011
-
负责人:Jie Chen
-
依托单位:
Phospholipase D signaling
-
批准号:8513351
-
项目类别:
-
资助金额:$40.62万
-
财政年份:2011
-
负责人:Jie Chen
-
依托单位:
Phospholipase D signaling
-
批准号:8016458
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2011
-
负责人:Jie Chen
-
依托单位:
Phosphatidic acid regulation of mTOR signaling
-
批准号:9762121
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2011
-
负责人:Jie Chen
-
依托单位:
Phospholipase D signaling
-
批准号:8642697
-
项目类别:
-
资助金额:$5.94万
-
财政年份:2011
-
负责人:Jie Chen
-
依托单位:
Phospholipase D signaling
-
批准号:8302246
-
项目类别:
-
资助金额:$28.32万
-
财政年份:2011
-
负责人:Jie Chen
-
依托单位:
Phosphoinositide signaling in autophagy
-
批准号:10530170
-
项目类别:
-
资助金额:$31.14万
-
财政年份:2011
-
负责人:Jie Chen
-
依托单位:
Phosphoinositide signaling in autophagy
-
批准号:10652628
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2011
-
负责人:Jie Chen
-
依托单位:
mTOR signaling in skeletal myogenesis
-
批准号:7847225
-
项目类别:
-
资助金额:$8.24万
-
财政年份:2009
-
负责人:Jie Chen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: